Agilent Technologies (A) valuation
Agilent Technologies P/E ratio history
Agilent Technologies trades at 34.4 times its earnings over the last twelve months and 26.5 times the earnings analysts expect over the next twelve. At its last 10 fiscal year ends its P/E ranged from 22.5 (year to Oct 2019) to 66.8 (year to Oct 2018), with a median of 32.2.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Oct 31, 2025 | $146.36 | $4.57 | 32.0 | 24.8 |
| Oct 31, 2024 | $130.31 | $4.43 | 29.4 | 23.5 |
| Oct 31, 2023 | $103.37 | $4.19 | 24.7 | 18.4 |
| Oct 31, 2022 | $138.35 | $4.18 | 33.1 | 26.6 |
| Oct 31, 2021 | $157.49 | $3.94 | 40.0 | 33.7 |
| Oct 31, 2020 | $102.09 | $2.30 | 44.4 | — |
| Oct 31, 2019 | $75.75 | $3.37 | 22.5 | — |
| Oct 31, 2018 | $64.79 | $0.97 | 66.8 | — |
| Oct 31, 2017 | $68.03 | $2.10 | 32.4 | — |
| Oct 31, 2016 | $43.57 | $1.40 | 31.1 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Agilent Technologies valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Agilent TechnologiesA | $49.4B | 34.4 | 26.5 | 6.7 |
| WatersWAT | $45.4B | 115.4 | 29.7 | 9.8 |
| IQVIAIQV | $44.0B | 32.6 | 19.2 | 2.5 |
| Mettler ToledoMTD | $33.8B | 37.8 | 33.8 | 8.2 |
| Charles River LaboratoriesCRL | $17.3B | — | 29.8 | 4.3 |
| Bio-TechneTECH | $11.4B | 62.6 | 35.7 | 9.4 |
| Peer median | 50.2 | 29.8 | 8.2 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: A financials · A returns
No forecast, no recommendation. This page describes Agilent Technologies from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.